I agree that this site is using cookies. You can find further informations here.
X
Wahlin, Björn E.
204  results:
Search for persons X
?
1

Redirecting NK cells to the lymph nodes to augment their ly..:

Sanz-Ortega, Laura ; Leijonhufvud, Caroline ; Schoutens, Lisanne...
npj Precision Oncology.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

High Complete Metabolic Response Rates with Epcoritamab SC ..:

Brody, Joshua ; Jørgensen, Judit ; Belada, David...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S357 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Treatment sequencing and impact of number of treatment line..:

Wästerlid, Tove ; Dietrich, Caroline E. ; Oksanen, Anna...
eJHaem.  5 (2024)  3 - p. 516-526 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Biomarker analysis of the ASPEN study comparing zanubrutini..:

Tam, Constantine S. ; Opat, Stephen ; D'Sa, Shirley...
Blood Advances.  8 (2024)  7 - p. 1639-1650 , 2024
Link: https://doi.org/10.1182/..
 
?
5

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory ..:

Trněný, Marek ; Avigdor, Abraham ; McKinney, Matthew S....
eClinicalMedicine.  63 (2023)  - p. 102130 , 2023
Link: https://doi.org/10.1016/..
 
?
6

IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S454 , 2023
Link: https://doi.org/10.1016/..
 
?
7

POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in ..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S210 , 2023
Link: https://doi.org/10.1016/..
 
?
8

2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis..:

Merrien, Magali ; Wasik, Agata M. ; Melén, Christopher M....
Cancers.  15 (2023)  5 - p. 1585 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Poster: IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plu..:

Sehn, Laurie H. ; Hubel, Kai ; Luminari, Stefano...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S172 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Poster: IBCL-117 ASPEN: Long-Term Follow-Up Results of a Ph..:

Castillo, Jorge J. ; Tam, Constantine S. ; Garcia-Sanz, Ramon...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S172 , 2022
Link: https://doi.org/10.1016/..
 
?
11

ABCL-439 Subcutaneous Epcoritamab With Gemcitabine + Oxalip..:

Brody, Joshua ; Wahlin, Björn E. ; Phillips, Tycel...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S379-S380 , 2022
Link: https://doi.org/10.1016/..
 
?
12

P032: Circulating immune biomarkers in classical Hodgkin ly..:

Mulder, Tom A. ; Andersson, Maria L. ; Peña-Pérez, Lucia...
HemaSphere.  6 (2022)  - p. 15-16 , 2022
Link: https://doi.org/10.1097/..
 
?
13

Poster: IBCL-460 Subcutaneous Epcoritamab With Rituximab + ..:

Falchi, Lorenzo ; Leppä, Sirpa ; Wahlin, Björn E....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S173 , 2022
Link: https://doi.org/10.1016/..
 
?
14

IBCL-460 Subcutaneous Epcoritamab With Rituximab + Lenalido..:

Falchi, Lorenzo ; Leppä, Sirpa ; Wahlin, Björn E....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S392 , 2022
Link: https://doi.org/10.1016/..
 
?
15

IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plus Lenali..:

Sehn, Laurie H. ; Hubel, Kai ; Luminari, Stefano...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S385-S386 , 2022
Link: https://doi.org/10.1016/..
 
1-15